# NOTE 36: REVENUE FROM CONTRACTS WITH CUSTOMERS

## GL Level Breakdown for NOTE 36
**Period: (Unaudited) Jun'25**

| GL Code | GL Description | Amount (₹) |
|---------|----------------|------------|
| 41101010 | Sales of Goods - Government Hospitals | 22,43,27,437.48 |
| 41101020 | Sales of Goods - Private Hospitals | 8,36,65,100.48 |
| 41101030 | Sales of Goods - Dealers | 23,05,28,837.18 |
| 41101040 | Sales of Goods - Free Standingl Laboratories (FSL) | 6,06,06,551.44 |
| 41101050 | Sales of Goods - AMCOW | 79,82,391.68 |
| 41101060 | Sales of Goods - Research | 2,26,33,387.10 |
| 41101070 | Sales of Goods - Academe | 2,03,57,344.55 |
| 41101080 | Sales of Goods - Molecular Diagnostics | 46,45,670.03 |
| 41101081 | Sales of Goods - Non-Government Organizations | 17,51,562.50 |
| 41101090 | Sales of Goods - Industrial | 31,66,359.37 |
| 41101092 | Sales of Goods - Third Party Laboratories | 0.00 |
| 41101098 | Sales of Goods - National Agencies | 16,84,642.86 |
| 41101091 | Sales of Goods - Global Manufacturers | 0.00 |
| 41101130 | Sales of Goods - Distributor | 0.00 |
| 41101110 | Sales Revenue | 9,70,031.25 |
| 41102010 | Sales of Services - Hospital Laboratories | 24,35,519.63 |
| 41102020 | Sales of Services - Private Hospitals | 2,73,615.18 |
| 41102030 | Sales of Services - Sub-distribution Networks | 9,03,738.76 |
| 41102040 | Sales of Services - Free Standing Laboratories | 59,029.46 |
| 41102060 | Sales of Services - Research | 2,75,414.28 |
| 41102070 | Sales of Services - Academe/Research Laboratories | 1,82,956.61 |
| 41102080 | Sales of Services - Molecular Diagnostics | 3,24,092.41 |
| 41102090 | Sales of Services - Local Manufacturers | 1,79,049.11 |
| 41102098 | Sales of Services - National Agencies | 88,594.64 |
| **Total:** | | **₹67,20,15,326.00** |

---

## NOTE 36: REVENUE FROM CONTRACTS WITH CUSTOMERS
**Period: (Unaudited) Jun'25**

| Particulars | Amount (₹) |
|-------------|------------|
| **(I) Disaggregation of Revenue** | |
| **Type of Goods/Service:** | |
| **Revenue from Sale of Goods/Products** | **65,27,09,315.92** |
| Sales of Goods - Government Hospitals | 22,43,27,437.48 |
| Sales of Goods - Private Hospitals | 8,36,65,100.48 |
| Sales of Goods - Dealers | 23,05,28,837.18 |
| Sales of Goods - Free Standing Laboratories (FSL) | 6,06,06,551.44 |
| Sales of Goods - AMCOW | 79,82,391.68 |
| Sales of Goods - Research | 2,26,33,387.10 |
| Sales of Goods - Academe | 2,03,57,344.55 |
| Sales of Goods - Molecular Diagnostics | 46,45,670.03 |
| Sales of Goods - Non-Government Organizations | 17,51,562.50 |
| Sales of Goods - Industrial | 31,66,359.37 |
| Sales of Goods - National Agencies | 16,84,642.86 |
| Sales Revenue | 9,70,031.25 |
| | |
| **Revenue from Services** | **47,22,010.08** |
| Sales of Services - Hospital Laboratories | 24,35,519.63 |
| Sales of Services - Private Hospitals | 2,73,615.18 |
| Sales of Services - Sub-distribution Networks | 9,03,738.76 |
| Sales of Services - Free Standing Laboratories | 59,029.46 |
| Sales of Services - Research | 2,75,414.28 |
| Sales of Services - Academe/Research Laboratories | 1,82,956.61 |
| Sales of Services - Molecular Diagnostics | 3,24,092.41 |
| Sales of Services - Local Manufacturers | 1,79,049.11 |
| Sales of Services - National Agencies | 88,594.64 |
| | |
| **Total Revenue (Note: Must reconcile with P&L Statement)** | **₹65,74,31,326.00** |
| | |
| **(II) Contract Balances (Current and Non-Current)** | |
| Contract Assets | ₹0.00 |
| Less: Impairment loss on Contract Assets | ₹0.00 |
| Contract Liabilities | ₹0.00 |
| | |
| **(III) Reconciliation of Revenue Recognised** | |
| Revenue recognised from amounts included in contract liabilities at the beginning of the period | ₹0.00 |
| Revenue recognised from amounts that were contract assets at the beginning of the period | ₹0.00 |
| | |
| **TOTAL REVENUE FROM CONTRACTS WITH CUSTOMERS** | **₹65,74,31,326.00** |

---

### Notes:
1. All revenue figures are presented gross (credit balances sign-flipped to positive) as per Ind AS 115 requirements.
2. No Contract Assets, Contract Liabilities, or their reconciliation items were identified in the trial balance data provided for the period (Unaudited) Jun'25.
3. The total revenue of ₹65,74,31,326.00 comprises revenue from sale of goods (₹65,27,09,315.92) and revenue from services (₹47,22,010.08).
4. This note complies with Schedule III requirements and Ind AS 115 (Revenue from Contracts with Customers).
5. Customer discounts (GL 41201010: ₹2,34,636.70) have been excluded from this note as they are contra-revenue items to be netted in the P&L statement presentation.